Jun 25 |
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
|
Jun 24 |
Peering Into Tonix Pharmaceuticals's Recent Short Interest
|
Jun 21 |
7 F-Rated Penny Stocks to Avoid This June
|
Jun 20 |
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
|
Jun 18 |
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
|
Jun 18 |
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
|
Jun 17 |
Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024
|
Jun 14 |
This Biopharma Stock Is Trading 23% Higher In Pre-Market After Wrapping Up $4M Public Offering
|
Jun 13 |
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
|
Jun 12 |
Tonix Pharma prices $4M public offering
|